These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1164818)

  • 21. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men.
    Tashkin DP; Shapiro BJ; Frank IM
    N Engl J Med; 1973 Aug; 289(7):336-41. PubMed ID: 4718513
    [No Abstract]   [Full Text] [Related]  

  • 22. Involvement of central alpha-adrenoceptors in the hypotensive and bradycardic effects of (--)-delta 9-trans-tetrahydrocannabinol.
    Lokhandwala MF; Pariani HK; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1977 Mar; 42(2):107-12. PubMed ID: 191263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of adrenalectomy on the cardiovascular responses to delta 1-tetrahydrocannabinol in rats.
    Li DM; Chung JP
    Clin Exp Pharmacol Physiol; 1978; 5(3):207-13. PubMed ID: 668209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
    Estrada U; Brase DA; Martin BR; Dewey WL
    Life Sci; 1987 Jul; 41(1):79-87. PubMed ID: 3037218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of physostigmine and delta-9-tetrahydrocannabinol in man.
    Freemon FR; Rosenblatt JE; EL-Yousef MK
    Clin Pharmacol Ther; 1975 Feb; 17(2):121-6. PubMed ID: 1091392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats.
    Li DM
    Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of delta9-tetrahydrocannabinol in conscious and anaesthetized dogs.
    Friedman E; Gershon S; Hine B; Torrelio M
    Br J Pharmacol; 1977 Apr; 59(4):561-3. PubMed ID: 858008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of tolerance to 9 -tetrahydrocannabinol in chimpanzees.
    Ferraro DP; Grilly DM
    Science; 1973 Feb; 179(4072):490-2. PubMed ID: 4705343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.
    Heishman SJ; Huestis MA; Henningfield JE; Cone EJ
    Pharmacol Biochem Behav; 1990 Nov; 37(3):561-5. PubMed ID: 1965045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction.
    Davies BH; Radcliffe S; Seaton A; Graham JD
    Thorax; 1975 Feb; 30(1):80-5. PubMed ID: 1124532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns.
    Feinberg I; Jones R; Walker J; Cavness C; Floyd T
    Clin Pharmacol Ther; 1976 Jun; 19(6):782-94. PubMed ID: 178475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of (--)delta-9-trans-tetrahydrocannabinol (delta-9-THC) on tests of psychoticism. A study of Eysenck's drug postulate on the effects of hallucinogens in relation to psychoticism (author's transl)].
    Dittrich A; Bickel P; Zimmer D
    Psychopharmacologia; 1975; 40(4):351-8. PubMed ID: 1096219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analgesic effect of delta-9-tetrahydrocannabinol.
    Noyes R; Brunk SF; Baram DA; Canter A
    J Clin Pharmacol; 1975; 15(2-3):139-43. PubMed ID: 1091664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory effects of delta-9-tetrahydrocannabinol.
    Bellville JW; Swanson GD; Aqleh KA
    Clin Pharmacol Ther; 1975 May; 17(5):541-8. PubMed ID: 1126111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of marihuana in man.
    Clark SC; Greene C; Karr GW; MacCannell KL; Milstein SL
    Can J Physiol Pharmacol; 1974 Jun; 52(3):706-19. PubMed ID: 4850891
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.
    Fredericks AB; Benowitz NL; Savanapridi CY
    J Pharmacol Exp Ther; 1981 Feb; 216(2):247-53. PubMed ID: 6257883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.